Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

European Journal of Oncology Nursing, published by ELSEVIER SCI LTD, is a premier, peer-reviewed journal dedicated to advancing the field of oncology nursing. With an impactful presence in the academic community, it holds a commendable Q2 ranking in the field of Medicine (miscellaneous) and a Q1 ranking in Oncology (nursing) for 2023, reflecting its significant contribution to nursing research and practice. The journal boasts a strong influence with a Scopus ranking of 7 out of 20 in its category, placing it in the 67th percentile. Since its inception in 1998, it has continued to provide a vital platform for disseminating quality research pertaining to the nursing care of cancer patients. Although it currently does not offer open access, the journal remains an essential resource for researchers, professionals, and students seeking to enhance their understanding of oncology nursing and improve patient care outcomes. Located in the United States, this journal is committed to fostering knowledge and promoting evidence-based practices in oncology nursing for years to come.

Rehabilitation Oncology, published by Lippincott Williams & Wilkins, is an essential academic journal dedicated to the interdisciplinary field of cancer rehabilitation. Since its inception in 2008, it has provided a platform for illuminating research, clinical practices, and innovative therapies aimed at improving the quality of life for cancer survivors. With an ISSN of 2168-3808 and an E-ISSN of 2381-2427, the journal covers a wide spectrum of topics, making significant contributions across various categories including Oncology, Rehabilitation, and Physical Therapy. Although currently not Open Access, the journal has garnered a notable 2023 Impact Factor status, placing it in the Q3 quadrant across multiple relevant disciplines as per the latest Scopus rankings. This reflects its growing influence in the rehabilitation community and offers vital insights for practitioners and researchers seeking to advance their understanding of patient care post-cancer treatment. With its focus on bridging the gap between research and real-world application, Rehabilitation Oncology serves as a vital resource for healthcare professionals committed to enhancing recovery outcomes in their patients.

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

The Journal of Adolescent and Young Adult Oncology, published by MARY ANN LIEBERT, INC, is a premier peer-reviewed journal dedicated to enhancing the understanding and treatment of cancers in adolescents and young adults. With an ISSN of 2156-5333 and an E-ISSN of 2156-535X, this journal specializes in providing vital insights into the unique challenges faced by younger cancer patients, promoting research and clinical best practices in this underrepresented population. The journal features a commendable ranking in the Q2 quartile for Oncology and Q1 quartile for Pediatrics, Perinatology, and Child Health—highlighting its impact and relevance in both fields. Its Scopus rankings also reflect a strong standing; positioned at Rank #107/330 in Pediatrics and Rank #225/404 in Oncology. While the journal operates under a subscription-based model, it aims to disseminate crucial research findings and innovative treatments through its engaging content that serves as an invaluable resource for researchers, clinicians, and students alike. Since its inception in 2014, the journal has been at the forefront of addressing the pressing issues pertinent to young cancer patients, making it a vital outlet for groundbreaking studies and clinical advancements within this critical area of healthcare.

The Australian Journal of Advanced Nursing, published by the Australian Nursing Federation, has established itself as a vital resource in the fields of nursing and advanced nursing practice since its inception in 1983. With an ISSN of 0813-0531 and an E-ISSN of 1447-4328, this peer-reviewed journal aims to disseminate high-quality research, innovative practices, and critical reviews that contribute to the advancement of nursing knowledge and education. With a commendable impact factor and currently positioned in the Q2 quartile in both Advanced and Specialized Nursing and miscellaneous Nursing categories as of 2023, the journal is ranked among the top publications in the field, reflecting its significance and influence in shaping nursing practices and policies in Australia and beyond. The journal provides open access options for a wider readership while specializing in progressive topics that address contemporary challenges in nursing, thus serving researchers, practitioners, and educators alike. It continues to be a cornerstone for advancing the professional development of nursing disciplines, supporting a community that thrives on evidence-based practice and interdisciplinary collaboration.

JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

The Journal of Pediatric Oncology Nursing, published by SAGE Publications Inc, serves as an essential resource for healthcare professionals and researchers dedicated to the field of pediatric nursing, particularly within oncology. With its ISSN of 1043-4542 and E-ISSN of 1532-8457, this journal has established itself as a key platform for disseminating high-quality research, innovative practices, and case studies that address the unique challenges faced in caring for children with cancer. Despite its coverage in Scopus being discontinued in 2021, the journal previously ranked 4th in the Nursing _ Pediatrics category, illustrating its impact with an 85th percentile rating, and it holds a 10th place rank in Nursing _ Oncology, demonstrating its ongoing relevance in the field. The journal's commitment to open access ensures that vital research findings are available to a global audience, assisting in the improvement of nursing practices and patient care. Engaging both seasoned professionals and aspiring researchers, the Journal of Pediatric Oncology Nursing continues to be a cornerstone for advancing knowledge and enhancing the quality of care for pediatric oncology patients.

Current Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.